1. Home
  2. AXR vs CSBR Comparison

AXR vs CSBR Comparison

Compare AXR & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • CSBR
  • Stock Information
  • Founded
  • AXR 1961
  • CSBR 1985
  • Country
  • AXR United States
  • CSBR United States
  • Employees
  • AXR N/A
  • CSBR N/A
  • Industry
  • AXR Homebuilding
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AXR Real Estate
  • CSBR Health Care
  • Exchange
  • AXR Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • AXR 114.8M
  • CSBR 111.4M
  • IPO Year
  • AXR N/A
  • CSBR 1986
  • Fundamental
  • Price
  • AXR $23.85
  • CSBR $7.97
  • Analyst Decision
  • AXR
  • CSBR Strong Buy
  • Analyst Count
  • AXR 0
  • CSBR 1
  • Target Price
  • AXR N/A
  • CSBR $12.00
  • AVG Volume (30 Days)
  • AXR 14.7K
  • CSBR 27.5K
  • Earning Date
  • AXR 09-12-2025
  • CSBR 09-10-2025
  • Dividend Yield
  • AXR N/A
  • CSBR N/A
  • EPS Growth
  • AXR 472.07
  • CSBR N/A
  • EPS
  • AXR 2.41
  • CSBR 0.46
  • Revenue
  • AXR $58,052,000.00
  • CSBR $58,591,000.00
  • Revenue This Year
  • AXR $120,108.69
  • CSBR $15.11
  • Revenue Next Year
  • AXR $8.16
  • CSBR $7.80
  • P/E Ratio
  • AXR $9.82
  • CSBR $17.75
  • Revenue Growth
  • AXR 30.35
  • CSBR 19.03
  • 52 Week Low
  • AXR $17.60
  • CSBR $3.60
  • 52 Week High
  • AXR $39.68
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • AXR 68.04
  • CSBR 52.81
  • Support Level
  • AXR $22.71
  • CSBR $7.16
  • Resistance Level
  • AXR $25.01
  • CSBR $9.63
  • Average True Range (ATR)
  • AXR 1.06
  • CSBR 0.66
  • MACD
  • AXR 0.26
  • CSBR 0.01
  • Stochastic Oscillator
  • AXR 74.18
  • CSBR 37.36

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: